Cerenome, Inc.
No trades
No trades
Compare with Cerenome, Inc.
−4.41 USD
−22.39 M USD
5.21 M USD
7.52 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Marc H. Hedrick
Website
Headquarters
Houston
Founded
1996
ISIN
US72941H8060
CUSIP
72941H806
FIGI
BBG000C1Z086
Identifiers
ISIN US72941H8060
Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of CNSY is 2.03 USD — it hasn't changed in the past 24 hours. Watch Cerenome, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cerenome, Inc. stocks are traded under the ticker CNSY.
CNSY stock has fallen by −15.42% compared to the previous week, the month change is a −33.66% fall, over the last year Cerenome, Inc. has showed a −80.68% decrease.
We've gathered analysts' opinions on Cerenome, Inc. future price: according to them, CNSY price has a max estimate of 50.00 USD and a min estimate of 43.00 USD. Watch CNSY chart and read a more detailed Cerenome, Inc. stock forecast: see what analysts think of Cerenome, Inc. and suggest that you do with its stocks.
CNSY reached its all-time high on Jan 2, 2001 with the price of 33,046,875.00 USD, and its all-time low was 2.00 USD and was reached on Sep 17, 2026. View more price dynamics on CNSY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CNSY stock is 5.00% volatile and has beta coefficient of 1.93. Track Cerenome, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cerenome, Inc. there?
Today Cerenome, Inc. has the market capitalization of 15.41 M, it has decreased by −10.26% over the last week.
Yes, you can track Cerenome, Inc. financials in yearly and quarterly reports right on TradingView.
Cerenome, Inc. is going to release the next earnings report on Oct 15, 2026. Keep track of upcoming events with our Earnings Calendar.
CNSY earnings for the last quarter are −1.31 USD per share, whereas the estimation was −0.88 USD resulting in a −48.86% surprise. The estimated earnings for the next quarter are −0.92 USD per share. See more details about Cerenome, Inc. earnings.
Cerenome, Inc. revenue for the last quarter amounts to 411.00 K USD, despite the estimated figure of 1.11 M USD. In the next quarter, revenue is expected to reach 1.25 M USD.
CNSY net income for the last quarter is −9.01 M USD, while the quarter before that showed −6.95 M USD of net income which accounts for 0.00% change. Track more Cerenome, Inc. financial stats to get the full picture.
No, CNSY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 20, 2026, the company has 28 employees. See our rating of the largest employees — is Cerenome, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cerenome, Inc. EBITDA is −25.96 M USD, and current EBITDA margin is −284.92%. See more stats in Cerenome, Inc. financial statements.
Like other stocks, CNSY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cerenome, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cerenome, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cerenome, Inc. stock shows the sell signal. See more of Cerenome, Inc. technicals for a more comprehensive analysis.